FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2008
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Musket David B 		2. Issuer Name and Ticker or Trading Symbol

MZT Holdings, Inc. [ MZT ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O MZT HOLDINGS, INC., 330 NEVADA STREET 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/24/2007
(Street)

NEWTON, MA 02460
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Conv Promissory Notes     (1) 12/24/2007     D        $1049359.63      (2)   (2) Common Stock   (3)   (3) $0   $193421.47   I   By various ProMed Funds   (4)
Series B Conv Promissory Notes     (1) 12/24/2007     D        $613894.64      (2)   (2) Common Stock   (5)   (5) $0   524188.23   I   By various ProMed Funds   (4)
Series A Conv Preferred Stock     (6) 12/27/2007     D        50692      (7)   (7) Common Stock   637270   $0   0   I   By various ProMed Funds   (4)
Series A Conv Preferred Stock     (6) 12/27/2007     D        6676      (7)   (7) Common Stock   83926   $0   0   D    
Series A Conv Promissory Notes     (1) 12/31/2007     D        $23380.15      (2)   (2) Common Stock   (3)   (3) $0   165550.85   I   By various ProMed Funds   (4)
Series B Conv Promissory Notes     (1) 12/31/2007     D        $68560.43      (2)   (2) Common Stock   (5)   (5) $0   456952.76   I   By various ProMed Funds  
Series A Conv Promissory Notes     (1) 1/2/2008     D        165675.13      (2)   (2) Common Stock   (3)   (3) $0   0   I   By various ProMed Funds   (4)
Series B Conv Promissory Notes     (1) 1/2/2008     D        $457281.94      (2)   (2) Common Stock   (5)   (5) $0   0   I   By various ProMed Funds   (4)
Series A Conv Promissory Notes     (1) 1/2/2008     D        $134674.94      (2)   (2) Common Stock   (3)   (3) $0   0   D    
Series B Conv Promissory Notes     (1) 1/2/2008     D        $356806.51      (2)   (2) Common Stock   (5)   (5) $0   0   D    

Explanation of Responses:
( 1)  The promissory notes were satisfied after maturity by cash payment by the issuer of principal, accrued interest and premium.
( 2)  The maturity date of the promissory notes was December 13, 2007.
( 3)  The holder of the Series A Convertible Promissory Notes had the right to convert them into shares of common stock of the issuer at a conversion price of $0.63 per share.
( 4)  ProMed Funds include ProMed Partners, L.P., ProMed Partners II, L.P., ProMed Offshore Fund, Ltd. and ProMed Offshore Fund II, Ltd. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in the Funds, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or any other purpose.
( 5)  The holder of the Series B Convertible Promissory Notes had the right to convert them into shares of common stock of the issuer at a conversion price of $0.63 per share.
( 6)  The liquidation preference of the Series A Convertible Preferred Stock paid by the issuer was $8.80 per share.
( 7)  The Series A Convertible Preferred Stock was convertible at the option of the holder into shares of the issuer's common stock at any time without payment of further consideration.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Musket David B
C/O MZT HOLDINGS, INC.
330 NEVADA STREET
NEWTON, MA 02460 		X X


Signatures
Patricia Randall, under power of attorney 1/2/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Matritech (AMEX:MZT)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Matritech Charts.
Matritech (AMEX:MZT)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Matritech Charts.